Stay updated on Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Sign up to get notified when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.

Latest updates to the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page
- ChecktodayChange DetectedA new revision entry v3.6.3 was added to the record history and the previous v3.6.2 entry was removed, reflecting an update to the study record's revision history.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page’s revision history now shows a new software revision (v3.6.2) replacing the previous v3.6.0. This reflects an update to the site’s underlying platform rather than changes to study content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe addition 'No longer looking for participants' indicates the study is no longer seeking enrollees, clarifying enrollment status within the history. A new revision tag 'Revision: v3.6.0' appears in the history, replacing the previous 'Revision: v3.5.5'.SummaryDifference0.4%

- Check29 days agoChange DetectedThe record history now includes a new revision entry (v3.5.5) and removes the previous revision (v3.5.4) from the history, updating the version trail for the study. This reflects a log-level update rather than a change to the study data.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.5.4 was added and the previous v3.5.3 was removed in the Study Record Versions, updating the page's revision history to reflect a newer revision of the study record.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.0 to v3.5.3, reflecting a minor ClinicalTrials.gov site release without altering the displayed study record history.SummaryDifference0.1%

Stay in the know with updates to Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Initial Myeloma: High-Dose vs Conventional RVD Clinical Trial page.